Get the Stockscreener App
61.00
1.43%
0.86
Monster Beverage Corp stock is traded at $61.00, with a volume of 8.26M.
It is up +1.43% in the last 24 hours and up +4.72% over the past month.
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to copackers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster with a 19.5% stake.
See More
Previous Close:
$60.14
Open:
$58.81
24h Volume:
8.26M
Relative Volume:
1.42
Market Cap:
$58.44B
Revenue:
$7.45B
Net Income/Loss:
$1.51B
P/E Ratio:
37.65
EPS:
1.62
Net Cash Flow:
$1.62B
1W Performance:
+1.58%
1M Performance:
+4.72%
6M Performance:
+12.67%
1Y Performance:
+10.51%
1-Day Range:
$58.62
$61.83
1-Week Range:
$58.62
$61.83
52-Week Range:
$43.32
$61.83
Monster Beverage Corp Stock (MNST) Company Profile
Name
Monster Beverage Corp
Sector
Industry
Phone
909-739-6200
Address
1 MONSTER WAY, CORONA, CA
Compare MNST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
61.00 | 58.44B | 7.45B | 1.51B | 1.62B | 1.62 |
|
KO
Coca Cola Co
|
70.52 | 308.40B | 46.89B | 10.78B | -928.00M | 2.50 |
|
PEP
Pepsico Inc
|
130.44 | 183.38B | 91.52B | 9.37B | 7.27B | 6.80 |
|
KOF
Coca Cola Femsa S A B De C V Adr
|
92.92 | 19.66B | 15.24B | 1.29B | 0 | 6.1525 |
|
PRMB
Primo Brands Corp
|
31.94 | 12.43B | 0 | 0 | 0 | 0.00 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Reiterated | JP Morgan | Neutral |
| May-09-25 | Reiterated | Morgan Stanley | Overweight |
| May-09-25 | Reiterated | Piper Sandler | Neutral |
| May-09-25 | Reiterated | TD Cowen | Hold |
| May-09-25 | Reiterated | UBS | Neutral |
| May-05-25 | Reiterated | Wells Fargo | Overweight |
| May-02-25 | Reiterated | JP Morgan | Neutral |
| Apr-25-25 | Reiterated | BofA Securities | Buy |
| Apr-23-25 | Reiterated | Truist | Sell |
| Apr-17-25 | Reiterated | UBS | Neutral |
| Apr-16-25 | Reiterated | Jefferies | Buy |
| Apr-14-25 | Reiterated | Citigroup | Buy |
| Apr-02-25 | Reiterated | Wells Fargo | Overweight |
| Mar-03-25 | Reiterated | UBS | Neutral |
| Feb-28-25 | Reiterated | Citigroup | Buy |
| Feb-28-25 | Reiterated | Deutsche Bank | Buy |
| Feb-28-25 | Reiterated | JP Morgan | Neutral |
| Feb-28-25 | Reiterated | Morgan Stanley | Overweight |
| Dec-19-24 | Reiterated | Exane BNP Paribas | Underperform |
| Dec-06-24 | Initiated | Needham | Hold |
| Nov-12-24 | Reiterated | Argus | Buy |
| Nov-11-24 | Reiterated | TD Cowen | Hold |
| Nov-08-24 | Reiterated | Deutsche Bank | Buy |
| Nov-08-24 | Reiterated | JP Morgan | Neutral |
| Nov-08-24 | Reiterated | Stifel | Buy |
| Nov-08-24 | Reiterated | UBS | Neutral |
| Nov-05-24 | Reiterated | Wells Fargo | Overweight |
| Nov-04-24 | Reiterated | JP Morgan | Neutral |
| Oct-15-24 | Reiterated | BofA Securities | Buy |
| Oct-07-24 | Reiterated | UBS | Neutral |
| Aug-12-24 | Reiterated | ROTH MKM | Neutral |
| Aug-09-24 | Reiterated | Truist | Sell |
| Aug-08-24 | Reiterated | Citigroup | Buy |
| Aug-08-24 | Reiterated | Deutsche Bank | Buy |
| Aug-08-24 | Reiterated | JP Morgan | Neutral |
| Aug-08-24 | Reiterated | Jefferies | Buy |
| Aug-08-24 | Reiterated | Piper Sandler | Neutral |
| Aug-08-24 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-24 | Reiterated | UBS | Neutral |
| Aug-08-24 | Reiterated | Wells Fargo | Overweight |
| Jul-23-24 | Reiterated | JP Morgan | Neutral |
| Jul-15-24 | Reiterated | TD Cowen | Hold |
| Jul-10-24 | Reiterated | BofA Securities | Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| Jun-25-24 | Reiterated | Wells Fargo | Overweight |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Jun-17-24 | Reiterated | Stifel | Buy |
| May-03-24 | Reiterated | Morgan Stanley | Overweight |
| May-03-24 | Reiterated | Piper Sandler | Neutral |
| May-03-24 | Reiterated | UBS | Neutral |
| Jan-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-17-24 | Reiterated | Citigroup | Buy |
| Jan-17-24 | Reiterated | Goldman | Buy |
| Jan-17-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-23 | Reiterated | Piper Sandler | Neutral |
| Nov-20-23 | Reiterated | ROTH MKM | Neutral |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Nov-03-23 | Reiterated | Wells Fargo | Overweight |
| Oct-31-23 | Reiterated | JP Morgan | Overweight |
| Oct-24-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-23-23 | Reiterated | Deutsche Bank | Buy |
| Oct-05-23 | Upgrade | CFRA | Hold → Buy |
| Aug-14-23 | Initiated | HSBC Securities | Buy |
| Aug-10-23 | Reiterated | ROTH MKM | Neutral |
| Aug-07-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-04-23 | Reiterated | UBS | Neutral |
| Jul-31-23 | Reiterated | Stifel | Buy |
| Jul-25-23 | Reiterated | Evercore ISI | Outperform |
| Jun-08-23 | Initiated | Piper Sandler | Neutral |
| May-08-23 | Reiterated | BMO Capital Markets | Market Perform |
| May-08-23 | Reiterated | ROTH MKM | Neutral |
| May-05-23 | Reiterated | BofA Securities | Buy |
| May-05-23 | Reiterated | Citigroup | Buy |
| May-05-23 | Reiterated | Deutsche Bank | Buy |
| May-05-23 | Reiterated | Goldman | Buy |
| May-05-23 | Reiterated | JP Morgan | Overweight |
| May-05-23 | Reiterated | Morgan Stanley | Overweight |
| May-05-23 | Reiterated | RBC Capital Mkts | Outperform |
| May-05-23 | Reiterated | Truist | Buy |
| May-05-23 | Reiterated | UBS | Neutral |
| May-05-23 | Reiterated | Wells Fargo | Overweight |
| Apr-06-23 | Reiterated | UBS | Neutral |
| Apr-06-23 | Reiterated | Wedbush | Neutral |
| Mar-06-23 | Upgrade | Redburn | Neutral → Buy |
| Mar-01-23 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-01-23 | Downgrade | CFRA | Buy → Hold |
| Mar-01-23 | Reiterated | Citigroup | Buy |
| Mar-01-23 | Reiterated | JP Morgan | Overweight |
| Mar-01-23 | Reiterated | Morgan Stanley | Overweight |
| Mar-01-23 | Reiterated | Truist | Buy |
| Mar-01-23 | Reiterated | Wells Fargo | Overweight |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-18-23 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-18-23 | Reiterated | Evercore ISI | Outperform |
| Nov-04-22 | Reiterated | BofA Securities | Buy |
| Nov-04-22 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-22 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-04-22 | Reiterated | UBS | Neutral |
| Nov-04-22 | Reiterated | Wells Fargo | Overweight |
| Nov-01-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-11-22 | Initiated | Wedbush | Neutral |
| Aug-05-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-05-22 | Initiated | ROTH Capital | Neutral |
| Jun-06-22 | Reiterated | Morgan Stanley | Overweight |
| May-18-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Feb-25-22 | Reiterated | Citigroup | Buy |
| Feb-25-22 | Reiterated | Cowen | Market Perform |
| Feb-25-22 | Reiterated | Deutsche Bank | Buy |
| Feb-25-22 | Reiterated | Guggenheim | Buy |
| Feb-25-22 | Reiterated | JP Morgan | Neutral |
| Feb-17-22 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Initiated | Redburn | Neutral |
| Oct-13-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| May-07-21 | Reiterated | Truist | Buy |
| Feb-26-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Jan-15-21 | Reiterated | Citigroup | Neutral |
| Jan-15-21 | Reiterated | Deutsche Bank | Buy |
| Jan-15-21 | Reiterated | Truist | Buy |
| Dec-10-20 | Reiterated | Morgan Stanley | Overweight |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Nov-17-20 | Upgrade | UBS | Sell → Neutral |
| Nov-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-20-20 | Reiterated | Guggenheim | Buy |
| May-28-20 | Reiterated | Stifel | Buy |
| May-11-20 | Downgrade | Citigroup | Buy → Neutral |
| May-05-20 | Reiterated | Guggenheim | Buy |
| Apr-16-20 | Resumed | BofA/Merrill | Buy |
| Apr-01-20 | Resumed | Goldman | Buy |
| Mar-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-17-19 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-02-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-08-19 | Reiterated | BMO Capital Markets | Market Perform |
| Aug-08-19 | Reiterated | Morgan Stanley | Equal-Weight |
| Aug-08-19 | Reiterated | UBS | Sell |
| Apr-01-19 | Downgrade | Macquarie | Outperform → Neutral |
| Mar-28-19 | Reiterated | Morgan Stanley | Equal-Weight |
View All
Monster Beverage Corp Stock (MNST) Latest News
Monster Beverage (NASDAQ:MNST) Price Target Raised to $63.00 - MarketBeat
Monster Beverage (NASDAQ:MNST) Given New $54.00 Price Target at Piper Sandler - MarketBeat
Monster Beverage Co. (NASDAQ:MNST) Shares Sold by FORA Capital LLC - MarketBeat
Bayesian Capital Management LP Sells 16,189 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage, a leader in the energy drink market, saw its stock price rise in April on the back.. - 매일경제
Monster Beverage Corporation (NASDAQ:MNST) Q1 2025 Earnings Call Transcript - Insider Monkey
Monster Beverage: The Big Boy Seems To Be Struggling (NASDAQ:MNST) - Seeking Alpha
Monster Beverage's Margins Are Looking Healthier Despite Recent Hiccups - Finimize
Monster Beverage sees strong April sales growth with robust Q2 outlook - MSN
Balyasny Asset Management L.P. Grows Position in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
UBS Adjusts Price Target for Monster Beverage (MNST) Amid Strong Q2 Performance | MNST Stock News - GuruFocus
Baird Financial Group Inc. Grows Stake in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Mercer Global Advisors Inc. ADV Decreases Position in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage (MNST) Sees Price Target Boost from Piper Sandl - GuruFocus
Monster Beverage (MNST) Price Target Raised by UBS | MNST Stock News - GuruFocus
Morgan Stanley Raises Price Target for Monster Beverage (MNST) | - GuruFocus
Morgan Stanley Boosts Target for Monster Beverage (MNST) to $65 - GuruFocus
Monster Beverage (MNST) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
JPMorgan raises Monster Beverage price target to $64 - Investing.com
Monster Beverage (NasdaqGS:MNST) Reports Flat Sales But Slight EPS Growth - simplywall.st
Monster Beverage (MNST) Rebounds with Strong April Sales - GuruFocus
Monster's Q1 sales fall flat, but April fuels analyst optimism - MSN
Morgan Stanley Raises Price Target for Monster Beverage (MNST) | MNST Stock News - GuruFocus
Monster's Q1 sales fall flat, but April fuels analyst optimism (MNST:NASDAQ) - Seeking Alpha
Monster Beverage Stock Trades at All-Time High on Strong April Sales - MSN
Monster Beverage Faces Improving Margin Trends After Q1 Revenue Miss, Deutsche Bank Says - marketscreener.com
Piper Sandler Raises Price Target for Monster Beverage (MNST) | MNST Stock News - GuruFocus
Monster Beverage (MNST) Reports Lower Q1 Revenue Amid Various Ch - GuruFocus
Monster: Low-Energy Q1 Sees Net Sales Drop, Alcohol Drag - BevNET.com
Morgan Stanley Boosts Target for Monster Beverage (MNST) to $65 | MNST Stock News - GuruFocus
Monster Beverage price target raised to $63 from $62 at UBS - TipRanks
Deutsche Bank Adjusts Monster Beverage Price Target to $68 From $66, Maintains Buy Rating - marketscreener.com
Monster Beverage Corporation (MNST) Earnings: 1Q25 Key Numbers - AlphaStreet
Morgan Stanley Raises Price Target on Monster Beverage to $65 From $60, Keeps Overweight Rating - marketscreener.com
Monster Beverage Co. (NASDAQ:MNST) Shares Bought by Aptus Capital Advisors LLC - MarketBeat
Crestline Management LP Acquires 5,913 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage Posts Surprise Fall In Quarterly Net Sales - European Supermarket Magazine
Monster Beverage Corp SEC 10-Q Report - TradingView
Caisse DE Depot ET Placement DU Quebec Boosts Stock Holdings in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage Posts Surprise Fall In Quarterly Net Sales On Choppy Demand - checkout.ie
Monster Beverage Q1 2025 Earnings Call Transcript - MarketBeat
Monster Beverage Corp (MNST) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
The Manufacturers Life Insurance Company Sells 8,663 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster's CEO: 'We Don't Always Win' On Hedging—As Aluminum Tariffs Bite Into Q2 Margins - Benzinga
Earnings call transcript: Monster Beverage misses Q1 2025 revenue forecast By Investing.com - Investing.com India
Monster Beverage (MNST) Sees Operating Income Rise Amid Q1 Sales Dip - GuruFocus
Monster Beverage Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Monster Beverage (MNST) Faces Sales Decline Amid Forex and Weath - GuruFocus
Monster Beverage posts surprise fall in quarterly net sales on choppy demand - Reuters
Earnings call transcript: Monster Beverage misses Q1 2025 revenue forecast - Investing.com
Monster Beverage: Q1 Earnings Snapshot - The Washington Post
Monster Beverage Corp Stock (MNST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Monster Beverage Corp Stock (MNST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HALL MARK J | Director |
Mar 14 '25 |
Option Exercise |
42.71 |
21,000 |
896,820 |
320,246 |
| HALL MARK J | Director |
Mar 13 '25 |
Option Exercise |
31.20 |
12,000 |
374,400 |
308,846 |
| HALL MARK J | Director |
Mar 14 '25 |
Sale |
55.00 |
21,000 |
1,155,000 |
299,246 |
| HALL MARK J | Director |
Mar 13 '25 |
Sale |
54.50 |
12,000 |
654,000 |
296,846 |
| Carling Guy | President of EMEA & OSP |
Mar 14 '25 |
Option Exercise |
30.65 |
37,000 |
1,134,000 |
68,993 |
| Carling Guy | President of EMEA & OSP |
Mar 14 '25 |
Sale |
55.02 |
47,000 |
2,585,940 |
21,993 |
0.05%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):